Federal Register / Vol. 73, No. 170 / Tuesday, September 2, 2008 / Notices 51309 

management system. Electronic 

comments or submissions will be 

accepted by FDA only through FDMS at 

http://www.regulations.gov. 

IV. References 

The following references have been 

placed on display in the Division of 

Dockets Management (see ADDRESSES) 

and may be seen by interested persons 

between 9 a.m. and 4 p.m., Monday 

through Friday. (FDA has verified the 

Web site addresses, but FDA is not 

responsible for any subsequent changes 

to the Web sites after this document 

publishes in the Federal Register.) 

1. Sivapalasingam, S., et al. ‘‘Fresh 

Produce: A Growing Cause of Outbreaks of 

Foodborne Illness in the United States, 1973 

through 1997,’’ Journal of Food Protection 

67(10): 2342–53, 2004. 

2. U.S. Food and Drug Administration, 

1996 to 2007 Produce Outbreaks 

(unpublished compilation). 

3. U.S. Food and Drug Administration, 

‘‘Guide to Minimize Microbial Food Safety 

Hazards for Fresh Fruits and Vegetables,’’

October 26, 1998, available at http:// 

www.cfsan.fda.gov/~dms/prodguid.html. 

4. U.S. Food and Drug Administration, 

‘‘Produce Safety From Production to 

Consumption: 2004 Action Plan to Minimize 

Foodborne Illness Associated with Fresh 

Produce Consumption,’’ October 2004, 

available at http://www.cfsan.fda.gov/~dms/ 

prodpla2.html. 

5. U.S. Food and Drug Administration, 

‘‘Leafy Greens Safety Initiative—2nd year,’’

October 4, 2007, available at http:// 

www.cfsan.fda.gov/~dms/lettsaf2.html. 

6. U.S. Food and Drug Administration, 

‘‘Tomato Safety Initiative,’’ June 12, 2007, 

available at http://www.cfsan.fda.gov/~dms/ 

tomsafe.html. 

7. ‘‘Safety of Fresh Produce; Public 

Hearings; Request for Comments’’ (72 FR 

8750, February 27, 2007), Public hearings 

held on March 20, 2007, and April 13, 2007, 

http://www.regulations.gov/fdmspublic/ 

component/ 

main?main=DocketDetail&d=FDA–2007–N–

0380. 

8. California Leafy Green Products Handler 

Marketing Agreement, available at http:// 

www.caleafygreens.ca.gov. 

II. Electronic Access 

Persons with access to the Internet 

may obtain the document at http:// 

www.cfsan.fda.gov/~dms/ 

prodguid.html. 

Dated: August 19, 2008. 

Jeffrey Shuren, 

Associate Commissioner for Policy and 

Planning. 

[FR Doc. E8–20187 Filed 8–29–08; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2008–N–0466] 

Over the Counter Cough and Cold 

Medication for Pediatric Use; Notice of 

Public Hearing; Correction 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of public hearing; request 

for comments; correction. 

SUMMARY: The Food and Drug 

Administration is correcting a notice 

that published in the Federal Register 

on August 25, 2008 (73 FR 50033). The 

notice announced a public hearing to 

obtain input regarding over-the-counter 

(OTC) cough and cold drugs marketed 

for pediatric use. Due to some confusion 

regarding electronic registration, this 

notice revises the electronic registration 

procedures, and corrects the address for 

the contact person. 

DATES: The correction is effective 

September 2, 2008. 

FOR FURTHER INFORMATION CONTACT: 

Faith Dugan, Food and Drug 

Administration, 10903 New Hampshire 

Ave., rm. 6182, Silver Spring, MD 

20993, 301–796–3446, 

Faith.Dugan@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In FR Doc. 

E8–19657, published on August 25, 

2008 (73 FR 50033), the following 

correction is made to ADDRESSES: 

1. On page 50033, in the first and 

second columns, the ADDRESSES section 

is corrected to read as follows: 

ADDRESSES: Submit written comments to 

the Division of Dockets Management 

(HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, 

rm. 1061, Rockville, MD 20852. 

E-mail electronic registration to: 

Faith.Dugan@fda.hhs.gov. Anyone who 

has already registered via http:// 

www.regulations.gov does not have to 

re-register. The agency will accept those 

registrations. 

Submit electronic comments to http:// 

www.regulations.gov. All comments 

should be identified with the docket 

number found in brackets in the 

heading of this document. 

Transcripts of the hearing will be 

available for review at the Division of 

Dockets Management and on the 

Internet at http://www.regulations.gov 

approximately 30 days after the hearing. 

For Registration to Attend and/or 

Participate in the Hearing: Seating at the 

hearing is limited. People interested in 

attending should submit electronic 

registration to Faith Dugan by close of 

business on September 15, 2008. 

Registration is free and will be on a firstcome, first-served basis. Written or 

electronic comments will be accepted 

until December 2, 2008. 

If you wish to make an oral 

presentation at the hearing, you must 

state your intention on your registration 

submission (see ADDRESSES). To speak, 

submit your name, title, business 

affiliation, address, telephone and fax 

numbers, and e-mail address. FDA has 

included questions for comment in 

section II of this document. You should 

also identify by number each question 

you wish to address in your 

presentation. FDA will do its best to 

accommodate requests to speak. 

Individuals and organizations with 

common interests are urged to 

consolidate or coordinate their 

presentations, and to request time for a 

joint presentation. FDA will determine 

the amount of time allotted to each 

presenter and the approximate time that 

each oral presentation is scheduled to 

begin. 

If you need special accommodations 

because of a disability, please inform 

Faith Dugan, (see For Information on the 

Hearing Contact). 

For Information on the Hearing 

Contact: Faith Dugan, Food and Drug 

Administration, 10903 New Hampshire 

Ave., rm. 6182, Silver Spring, MD 20993 

, 301–796–3446, FAX: 301–847–4752, email: Faith.Dugan@fda.hhs.gov. 

Dated: August 27, 2008. 

Jeffrey Shuren, 

Associate Commissioner for Policy and 

Planning. 

[FR Doc. E8–20370 Filed 8–28–08; 11:15 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 


erowe on PROD1PC64 with NOTICES
51310 Federal Register / Vol. 73, No. 170 / Tuesday, September 2, 2008 / Notices 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Neurological Sciences 

Training Initial Review Group, NST–1 

Subcommittee. 

Date: September 8–9, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The M Street Renaissance Hotel, 

1143 New Hampshire Avenue, NW., 

Washington, DC 20037. 

Contact Person: Raul A. Saavedra, PhD, 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Research, 

NINDS/NIH/DHHS, NSC; 6001 Executive 

Blvd., Ste. 3208, Bethesda, MD 20892–9529, 

301–496–9223, saavedrr@ninds.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS). 

Dated: August 25, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E8–20183 Filed 8–29–08; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Deafness and 

Other Communication Disorders; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel, T35 

Short-Term Institutional Research Training 

Grant. 

Date: September 24, 2008. 

Time: 12 p.m. to 1:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6120 

Executive Blvd., Rockville, MD 20852 

(Telephone Conference Call). 

Contact Person: Christopher Moore, PhD, 

Scientific Review Officer, Division of 

Extramural Activities, National Institutes of 

Health/NIDCD, 6120 Executive Blvd, Rm. 

400C, Bethesda, MD 20892–7180, 301–402–

3587, moorechristopher@nidcd.nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel, P30 

Research Core Center. 

Date: September 30, 2008. 

Time: 1:30 a.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6120 

Executive Blvd., Rockville, MD 20852 

(Telephone Conference Call). 

Contact Person: Christine A. Livingston, 

PhD, Scientific Review Administrator, 

Division of Extramural Activities, National 

Institutes of Health/ NIDCD, 6120 Executive 

Blvd.—MSC 7180, Bethesda, MD 20892, 

(301) 496–8683, livingsc@mail.nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel, R03 

Hearing and Balance. 

Date: October 7, 2008. 

Time: 12 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6120 

Executive Blvd., Rockville, MD 20852 

(Telephone Conference Call). 

Contact Person: Sheo Singh, PhD, 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Activities, 

Executive Plaza South, Room 400C, 6120 

Executive Blvd., Bethesda, MD 20892, 301–

496–8683, singhs@nidcd.nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel, R03 

Voice, Speech, & Language. 

Date: October 9, 2008. 

Time: 12 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6120 

Executive Blvd., Rockville, MD 20852 

(Telephone Conference Call). 

Contact Person: Christopher Moore, PhD, 

Scientific Review Officer, Division of 

Extramural Activities, National Institutes of 

Health/NIDCD, 6120 Executive Blvd, Rm. 

400C, Bethesda, MD 20892–7180. 301–402–

3587, moorechristopher@nidcd.nih.gov. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.173, Biological Research 

Related to Deafness and Communicative 

Disorders, National Institutes of Health, 

HHS). 

Dated: August 25, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E8–20184 Filed 8–29–08; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, AD 

Coordinating Center. 

Date: September 26, 2008. 

Time: 12 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Gateway, 7201 Wisconsin Avenue, Suite 

2C212, Bethesda, MD 20814 (Telephone 

Conference Call). 

Contact Person: Alicja L. Markowska, PhD, 

DSC, National Institute on Aging, 7201 

Wisconsin Avenue, Suite 2C212, Bethesda, 

MD 20814, 301–496–9666, 

markowsa@nia.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, Alzheimer 

Pathogenesis I. 

Date: October 2, 2008. 

Time: 3 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Bldg., 7201 Wisconsin Avenue, Rm 

2C212, Bethesda, MD 20814 (Telephone 

Conference Call). 

Contact Person: Bita Nakhai, PhD, 

Scientific Review Administrator, Scientific 

Review Office, National Institute on Aging, 

Gateway Bldg., 2C212, 7201 Wisconsin 

Avenue, Bethesda, MD 20814, 301–402–

7701, nakhaib@nia.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, Mitochondria 

in Neurodegenerative Disease I. 


erowe on PROD1PC64 with NOTICES